Inventor
BRYS REGINALD CHRISTOPHE XAVIER
FR20 patents
⚠️ This page may combine multiple inventors who share the name “BRYS REGINALD CHRISTOPHE XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALAPAGOS NV
13 patentsUS9249141B2Feb 2, 2016
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV9 citations91
US10526329B2Jan 7, 2020
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV4 citations83
US10125132B2Nov 13, 2018
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV6 citations83
US9670204B2Jun 6, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV10 citations83
US8993590B2Mar 31, 2015
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV8 citations83
US11072611B2Jul 27, 2021
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations72
US11564923B2Jan 31, 2023
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations68
US9796719B2Oct 24, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV1 citations51
US12383544B2Aug 12, 2025
Methods for the treatment of polycystic kidney disease
GALAPAGOS NV0 citations49
US12264156B2Apr 1, 2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations46
US9951337B2Apr 24, 2018
Methods and means for treatment of osteoarthritis
GALAPAGOS NV0 citations43
US9945843B2Apr 17, 2018
Methods for identifying compounds that inhibit G protein-coupled receptor (GPR84) agonist-stimulated chemotaxis
GALAPAGOS NV0 citations42
US10508111B2Dec 17, 2019
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
GALAPAGOS NV0 citations34
BRYS REGINALD CHRISTOPHE XAVIER
2 patentsUS8637257B2Jan 28, 2014
Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
BRYS REGINALD CHRISTOPHE XAVIER3 citations55
US8663930B2Mar 4, 2014
Methods and means for treatment of osteoarthritis
BRYS REGINALD CHRISTOPHE XAVIER0 citations39
ANDREWS MARTIN JAMES INGLIS
2 patentsUS8178530B2May 15, 2012
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations49
US8173656B2May 8, 2012
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations49